KDA Stock Overview
KDA Group Inc., together with its subsidiaries, provides solutions and services to pharmacies and pharmaceutical companies in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
KDA Group Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.41 |
| 52 Week High | CA$0.66 |
| 52 Week Low | CA$0.03 |
| Beta | 1.06 |
| 1 Month Change | 1.25% |
| 3 Month Change | 62.00% |
| 1 Year Change | 350.00% |
| 3 Year Change | 189.29% |
| 5 Year Change | 92.86% |
| Change since IPO | 170.00% |
Recent News & Updates
Recent updates
KDA Group (CVE:KDA) Use Of Debt Could Be Considered Risky
Oct 19
More Unpleasant Surprises Could Be In Store For KDA Group Inc.'s (CVE:KDA) Shares After Tumbling 28%
Aug 19A Look At The Intrinsic Value Of KDA Group Inc. (CVE:KDA)
Jul 09KDA Group (CVE:KDA) Takes On Some Risk With Its Use Of Debt
May 20A Look At The Intrinsic Value Of KDA Group Inc. (CVE:KDA)
Dec 24Shareholder Returns
| KDA | CA Healthcare | CA Market | |
|---|---|---|---|
| 7D | 1.3% | -0.9% | 0.7% |
| 1Y | 350.0% | -1.5% | 4.9% |
Price Volatility
| KDA volatility | |
|---|---|
| KDA Average Weekly Movement | 15.9% |
| Healthcare Industry Average Movement | 5.7% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in CA Market | 18.1% |
| 10% least volatile stocks in CA Market | 3.0% |
Volatility Over Time: KDA's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | n/a | Marc Lemieux | groupekda.ca |
KDA Group Inc., together with its subsidiaries, provides solutions and services to pharmacies and pharmaceutical companies in Canada. The company operates through three segments: Pharmacy Services, Pharmaceutical Solutions, and Technology. It provides pharmacy staff replacement services, professional and continued medical training services, pharmacy re-engineering services, and pharmaceutical training services.
KDA Group Inc. Fundamentals Summary
| KDA fundamental statistics | |
|---|---|
| Market cap | CA$71.04m |
| Earnings (TTM) | CA$193.93k |
| Revenue (TTM) | CA$186.28k |
366.3x
P/E Ratio381.4x
P/S RatioIs KDA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KDA income statement (TTM) | |
|---|---|
| Revenue | CA$186.28k |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$186.28k |
| Other Expenses | -CA$7.66k |
| Earnings | CA$193.93k |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0011 |
| Gross Margin | 100.00% |
| Net Profit Margin | 104.11% |
| Debt/Equity Ratio | 6.2% |
How did KDA perform over the long term?
See historical performance and comparison